Childhood cancer survivors have higher risk of deadly heart disease in pregnancy

May 27, 2018, European Society of Cardiology

Girls who survive cancer have a higher risk of developing a deadly heart disease when pregnant later in life, according to a study presented today at Heart Failure 2018 and the World Congress on Acute Heart Failure, a European Society of Cardiology congress.

Researchers say young survivors should be warned of this pregnancy-associated called peripartum cardiomyopathy so that they can be closely monitored. Separately, the researchers found that women with existing peripartum cardiomyopathy are at increased risk of developing cancer.

"Our finding that cancer and peripartum cardiomyopathy share some biological markers in the blood suggests that there is a physiological connection between these diseases," said Professor Denise Hilfiker-Kleiner, author of the study and Dean of Research in Molecular Cardiology, Hannover Medical School, Germany.

Peripartum cardiomyopathy is a life-threatening type of failure where the heart becomes enlarged and weak in late pregnancy or after childbirth. It occurs in about one in 1,000 pregnant women worldwide. "Without treatment, up to 30% of women die and less than half of patients fully recover," said Professor Johann Bauersachs, Director of the Department of Cardiology and Angiology, Hannover Medical School.

"It has been suspected, without having real data, that cardiotoxic anticancer treatment injures the heart and years later a second stress on the heart like pregnancy induces cardiomyopathy," said Professor Hilfiker-Kleiner. "Our study provides evidence for links between the two diseases."

The two-part study was conducted using German registry data. In part one, Stella Schlothauer, a young medical student in Professor Hilfiker-Kleiner's lab, compared the ten-year prevalence of cancer, which occurred before or after peripartum cardiomyopathy in 207 women to the ten-year cancer prevalence in the general population of women aged 0-49 years in Germany.

Thirteen of the 207 women with peripartum cardiomyopathy had cancer during the ten-year period—a prevalence of 6.3%. One woman had two cancers. Of the 14 cancer diagnoses, nine occurred before peripartum cardiomyopathy and five occurred after peripartum cardiomyopathy. The ten-year cancer prevalence in the general population of women in Germany aged 0-49 years was 0.59%.

Professor Hilfiker-Kleiner said: "Women with peripartum cardiomyopathy had ten times more cancer, either before or after their heart failure, than the of women. About two-thirds of cancers occurred in children or young adults who then developed peripartum cardiomyopathy, while one-third were diagnosed two to three years after peripartum cardiomyopathy. We think there may be genetic or epigenetic factors which make women more prone to both diseases. This is on top of the long-term cardiotoxic effects of anticancer therapies."

In part two, the researchers analysed the blood of 47 women with peripartum cardiomyopathy and 29 healthy women of the same age and time since pregnancy to look for peptides and proteins associated with cancer. Levels of several of these cancer markers were higher in the peripartum cardiomyopathy group—for example human epidermal growth factor receptor 2 (HER2), a protein which is elevated in around one in five breast cancers. Compared to healthy women, cancer markers were elevated in women with peripartum regardless of whether or not they had previous or subsequent cancer during the study.

"Cancer survivors should be warned that they are at increased risk of pregnancy-associated heart failure," said Professor Hilfiker-Kleiner. "These are high-risk pregnancies and women need close monitoring of their hearts for any sign of heart failure. We need more data so that we can tell pregnant with a history of cancer how high their risk of developing a second deadly disease is."

"Women who develop are at higher risk of subsequent cancer and should make sure they attend routine cancer screening," she said.

Explore further: Researchers identify cause of heart failure in pregnant women

More information: The abstract 'High prevalence of cancer in patients with peripartum cardiomyopathy: is there a pathophysiological connection between these two entities?' will be presented during the session Young Investigator Award: Clinical which takes place on 27 May.

Related Stories

Researchers identify cause of heart failure in pregnant women

January 6, 2016
Each year approximately 1 in 1,000 pregnant women will experience peripartum cardiomyopathy, an uncommon form of often severe heart failure that occurs in the final month of pregnancy or up to five months following delivery. ...

A potential biomarker for pregnancy-associated heart disease?

April 24, 2013
Peripartum cardiomyopathy (PPCM) is a deterioration in cardiac function that occurs in pregnant women during the last month or in the months following their pregnancy. This disorder can occur in women with no prior history ...

Pregnancy-related heart failure strikes black women twice as often as those of other races

October 11, 2017
African American women were found to be twice as likely to be diagnosed with peripartum cardiomyopathy as compared to women of Caucasian, Hispanic/Latina, Asian, and other ethnic backgrounds, according to a new study—the ...

Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth

May 17, 2014
Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing ...

Peripartum cardiomyopathy occurs globally and is not a disease of the poor

March 8, 2017
Peripartum cardiomyopathy (PPCM) occurs globally and is not a disease of the poor, according to research published today in the European Journal of Heart Failure. Cases were reported from many countries for the first time.

Recommended for you

No sweat required: Team finds hypertension treatment that mimics effect of exercise

October 16, 2018
Couch potatoes rejoice—there might be a way to get the blood pressure lowering benefits of exercise in pill form.

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Why heart contractions are weaker in those with hypertrophic cardiomyopathy

October 16, 2018
When a young athlete suddenly dies of a heart attack, chances are high that they suffer from familial hypertrophic cardiomyopathy (HCM). Itis the most common genetic heart disease in the US and affects an estimated 1 in 500 ...

Novel genetic study sheds new light on risk of heart attack

October 12, 2018
Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.

Researchers say ritual for orthodox Jewish men may offer heart benefits

October 11, 2018
A pilot study led by researchers at the University of Cincinnati (UC) College of Medicine suggests Jewish men who practice wearing tefillin, which involves the tight wrapping of an arm with leather banding as part of daily ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.